Results 271 to 280 of about 71,423 (312)

Untypical bilateral breast cancer with peritoneal fibrosis on ¹⁸F-FDG PET/CT: case report and literature review. [PDF]

Front Med (Lausanne)
Song L, Qiu Y, Huang W, Sun X, Yang Q, Peng Y, Kang L.   +6 more
europepmc   +1 more source

LncRNA RPL29P2 promotes peritoneal fibrosis and impairs peritoneal transport function via miR-1184 in peritoneal dialysis. [PDF]

Int J Med Sci
Li H, Zhang Y, Che M, Wang H, Li S, He P, Sun S, Xu G, Huang C, Liu X, Bai M, Zhou M, Su B, Zhang P, He L.   +14 more
europepmc   +1 more source

Hormonal Counterregulation during standardized Hypoglycemia Test comparing Biosynthetic Human Proinsulin and Human Insulin [PDF]

, 1985
Ball, P., Lühe, C. von der, Müller-Esch, G., Schlüter, K. J., Scriba, Peter Christian   +4 more
core  

MiR-132-3p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting TGF-β1/Smad2/3 signaling pathway. [PDF]

PLoS One
Yin Y, Yang Y, Zhang Y, Shang Y, Li Q, Yuan J.   +5 more
europepmc   +1 more source

Role of peritoneal mesothelial cells and the inflammatory response in peritoneal fibrosis

, 2011
Xuan Wu
openalex   +1 more source

[Practolol (Eraldin)-induced peritoneal fibrosis?].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1976
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Peritoneal fibrosis and epigenetic modulation

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2020
Peritoneal dialysis (PD) is an effective treatment for patients with end-stage renal disease. However, peritoneal fibrosis (PF) is a common complication that ultimately leads to ultrafiltration failure and discontinuation of PD after long-term PD therapy. There is currently no effective therapy to prevent or delay this pathologic process.
Yi Wang, Yingfeng Shi, Min Tao, Shougang Zhuang, Na Liu   +4 more
openaire   +2 more sources

Peritoneal Fibrosis Intervention

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2007
Peritoneal fibrosis (PF) is invariably observed in patients undergoing long-term peritoneal dialysis (PD). The condition is thought to occur in response to a variety of insults, including bioincompatible dialysates (acidic solution, high glucose, glucose degradation products, or a combination), peritonitis, uremia, and chronic inflammation.
Kayo, Kaneko, Chieko, Hamada, Yasuhiko, Tomino   +2 more
openaire   +2 more sources

Tissue Models of Peritoneal Fibrosis

The International Journal of Artificial Organs, 2005
Objective To evaluate the utility of peritoneal pathologic samples, unrelated to peritoneal dialysis (PD) treatment, for the study of peritoneal fibrosis and inflammation. Methods Comparative morphologic and immunohistochemical study of peritoneal pathologic samples unrelated to PD with peritoneal biopsies from PD patients with special emphasis on the ...
J A, Jimenez-Heffernan, A, Cirugeda, M A, Bajo, G, Del Peso, M L, Perez-Lozano, C, Perna, R, Selgas, M, Lopez-Cabrera   +7 more
openaire   +2 more sources

Molecular pathways in peritoneal fibrosis

Cellular Signalling, 2020
Peritoneal dialysis (PD) is a renal replacement therapy for patients with end-stage renal disease that is equivalent to hemodialysis with respect to adequacy, mortality, and other outcome parameters, yet providing superior quality-of-life measures and cost savings.
openaire   +2 more sources